Surgical Innovations to Announce Interim Results with Investor Briefing

The latest announcement is out from Surgical Innovations ( (GB:SUN) ).

Surgical Innovations Group plc announced the release of its interim results for the first half of 2025, scheduled for 29 September 2025. The company will hold a live presentation for investors, led by CEO David Marsh and CFO Brent Greetham, to discuss these results. This event is accessible to all current and potential shareholders, highlighting the company’s commitment to transparency and engagement with its stakeholders.

The most recent analyst rating on (GB:SUN) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on Surgical Innovations stock, see the GB:SUN Stock Forecast page.

Spark’s Take on GB:SUN Stock

According to Spark, TipRanks’ AI Analyst, GB:SUN is a Neutral.

Surgical Innovations’ overall stock score is driven by positive technical analysis and supportive corporate events. However, financial performance and valuation issues, such as negative profitability and unattractive valuation metrics, weigh down the score.

To see Spark’s full report on GB:SUN stock, click here.

More about Surgical Innovations

Surgical Innovations Group plc specializes in designing, manufacturing, and distributing innovative medical products primarily for minimally invasive surgery. Their offerings include branded port access systems, surgical instruments, and retraction devices, which are sold in the UK and exported globally. The company emphasizes environmentally responsible solutions with their ‘resposable’ products, combining reusable and disposable components. They also distribute specialist products for various surgeries and collaborate with OEM partners and industrial partners for precision engineering solutions.

Average Trading Volume: 667,712

Technical Sentiment Signal: Hold

Current Market Cap: £6.53M

For detailed information about SUN stock, go to TipRanks’ Stock Analysis page.